We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$46.8B
AUM Growth
-$2.48B
Cap. Flow
-$831M
Cap. Flow %
-1.77%
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$130M
2
AMGN icon
Amgen
AMGN
+$96.1M
3
PGR icon
Progressive
PGR
+$94.9M
4
ABBV icon
AbbVie
ABBV
+$77.1M
5
KVUE icon
Kenvue
KVUE
+$75.6M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$148M
2
JNJ icon
Johnson & Johnson
JNJ
+$147M
3
LYB icon
LyondellBasell Industries
LYB
+$108M
4
DG icon
Dollar General
DG
+$91.2M
5
XOM icon
ExxonMobil
XOM
+$87.6M

Sector Composition

Rank Sector Weight
1 Technology 24.48%
2 Healthcare 17.42%
3 Financials 12.53%
4 Consumer Discretionary 9.71%
5 Communication Services 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRVN icon
1701
Driven Brands
DRVN
$2.47B
$272K ﹤0.01%
21,600
LIND icon
1702
Lindblad Expeditions
LIND
$1.95B
$266K ﹤0.01%
36,920
EMBC icon
1703
Embecta
EMBC
$218M
$265K ﹤0.01%
17,630
VTOL icon
1704
Bristow Group
VTOL
$1.33B
$264K ﹤0.01%
9,376
+550
+6% +$15.9K
PNTG icon
1705
Pennant Group
PNTG
$1.43B
$263K ﹤0.01%
23,632
PETS icon
1706
PetMed Express
PETS
$42.3M
$263K ﹤0.01%
25,627
MYGN icon
1707
Myriad Genetics
MYGN
$476M
$262K ﹤0.01%
16,350
NFBK
1708
DELISTED
Northfield Bancorp
NFBK
$262K ﹤0.01%
27,750
SIRI icon
1709
SiriusXM
SIRI
$11B
$259K ﹤0.01%
5,735
-32,392
-85% -$1.51M
NAMSW icon
1710
NewAmsterdam Pharma Warrant
NAMSW
$81.7M
$255K ﹤0.01%
150,000
FLNA
1711
Filana Therapeutics
FLNA
$42M
$254K ﹤0.01%
15,280
GSBC icon
1712
Great Southern Bancorp
GSBC
$878M
$252K ﹤0.01%
5,250
AVD icon
1713
American Vanguard Corp
AVD
$68.7M
$250K ﹤0.01%
22,867
SSP icon
1714
E.W. Scripps
SSP
$270M
$248K ﹤0.01%
45,334
MNSO icon
1715
MINISO
MNSO
$3.88B
$247K ﹤0.01%
9,550
VERA icon
1716
Vera Therapeutics
VERA
$2.33B
$244K ﹤0.01%
17,816
FARO
1717
DELISTED
Faro Technologies
FARO
$242K ﹤0.01%
15,860
ATHM icon
1718
Autohome
ATHM
$2.62B
$235K ﹤0.01%
7,750
HEI icon
1719
HEICO Corp
HEI
$49.6B
$227K ﹤0.01%
1,400
-21,075
-94% -$3.58M
ENTA icon
1720
Enanta Pharmaceuticals
ENTA
$362M
$226K ﹤0.01%
20,250
+4,800
+31% +$77.3K
PACK icon
1721
Ranpak Holdings
PACK
$500M
$224K ﹤0.01%
41,230
IQ icon
1722
iQIYI
IQ
$1.19B
$209K ﹤0.01%
44,150
SPWR
1723
DELISTED
SunPower Corporation Common Stock
SPWR
$208K ﹤0.01%
33,760
JBIO
1724
Jade Biosciences
JBIO
$1.18B
$204K ﹤0.01%
429
TBRG
1725
DELISTED
TruBridge
TBRG
$200K ﹤0.01%
12,530

Similar funds

Ensign Peak Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
  • Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
  • Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
  • Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
  • Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
  • Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.

Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.